Search Results
Found 1 results
510(k) Data Aggregation
(20 days)
CLINIQA Liquid QC™ Tumor Marker Control for serum protein and tumor marker analysis is intended for use as an assayed quality control material for serum protein and tumor marker analysis
CLINIQA Liquid QC™ Tumor Marker Control Level 1 CLINIQA Liquid QC™ Tumor Marker Control Level 2 CLINIQA Liquid QC™ Tumor Marker Control Level 3 CLINIQA Liquid QCTM Tumor Marker Control, Tri-Level
This document is a 510(k) premarket notification from the FDA to Cliniqa Corporation regarding their CLINIQA Liquid QC™ Tumor Marker Control. It states that the device is substantially equivalent to legally marketed predicate devices and can be marketed.
The document does not contain any information about acceptance criteria, device performance, sample sizes used, data provenance, ground truth establishment, expert qualifications, adjudication methods, or comparative effectiveness studies.
The content is primarily a regulatory approval letter. Therefore, I cannot fulfill your request for information regarding acceptance criteria and study details based on the provided text.
Ask a specific question about this device
Page 1 of 1